Replacement and suicide gene therapy for targeted treatment of lung cancer.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Lung Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3816/CLC.2005.N.002PMID 15694015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progress in the therapy of small cell lung cancer.

  2004cited by this paper
• The development of gene therapy for diseases of the lung

  2004cited by this paper
• 454 Highly active, cancer specific promoters for gene therapy of small cell lung cancer

  2004cited by this paper
• Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.

  2004cited by this paper
• Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung Cancer

  2004cited by this paper
• Development of a Cancer-Targeted Tissue-Specific Promoter System

  2004cited by this paper
• Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line.

  2004cited by this paper
• Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

  2003cited by this paper
• Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box.

  2003cited by this paper
• Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences

  2003cited by this paper
• Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration.

  2003cited by this paper
• Transcriptional gene expression profiling of small cell lung cancer cells.

  2003cited by this paper
• Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector

  2003cited by this paper
• hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity

  2002cited by this paper
• Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells.

  2002cited by this paper
• Global and regional estimates of cancer mortality and incidence by site: II. results for the global burden of disease 2000

  2002cited by this paper
• Ganciclovir prodrug therapy is effective in a murine xenotransplant model of human lung cancer.

  2002cited by this paper
• Gutted adenoviral vector growth using E1/E2b/E3‐deleted helper viruses

  2002cited by this paper
• Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site

  2002cited by this paper
• Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.

  2002cited by this paper
• Ectopic expression of herpes simplex virus‐thymidine kinase gene in human non‐small cell lung cancer cells conferred caspase‐activated apoptosis sensitized by ganciclovir

  2002cited by this paper
• Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.

  2001cited by this paper
• Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter.

  2001cited by this paper
• Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector.

  2001cited by this paper
• Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study.

  2001cited by this paper
• Adenovirus‐mediated gene therapy specific for small cell lung cancer cells using a Myc‐Max binding motif

  2001cited by this paper
• Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma.

  2001cited by this paper
• Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

  2001cited by this paper
• Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.

  2000cited by this paper
• Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review.

  2000cited by this paper
• Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

  2000cited by this paper
• A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma Multiforme

  2000cited by this paper
• Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection.

  2000cited by this paper
• Use of gastrin‐releasing peptide promoter for specific expression of thymidine kinase gene in small‐cell lung carcinoma cells

  2000cited by this paper
• Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.

  2000cited by this paper
• Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma

  2000cited by this paper
• Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines.

  2000cited by this paper
• A Phase 1-2 Clinical Trial of Gene Therapy for Recurrent Glioblastoma Multiforme by Tumor Transduction with the Herpes Simplex Thymidine Kinase Gene Followed by Ganciclovir

  1999cited by this paper
• Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer

  1999cited by this paper
• Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.

  1999cited by this paper
• Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.

  1999cited by this paper
• Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.

  1999cited by this paper
• Activation of RB tumor suppressor protein and growth suppression of small cell lung carcinoma cells by reintroduction of p16INK4A gene.

  1999cited by this paper
• Induced Expression of p16INK4a Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes

  1999cited by this paper
• Mechanisms of G2 arrest in response to overexpression of p53.

  1999cited by this paper
• Glucocorticoid inhibition of human SP-A1 promoter activity in NCI-H441 cells.

  1999cited by this paper
• A Phase I Study of Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients with Advanced Non-Small Cell Lung Cancer

  1998cited by this paper
• Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver

  1998cited by this paper
• The 5′‐flanking region of human CD24 gene has cell‐type‐specific promoter activity in small‐cell lung cancer

  1998cited by this paper
• Toxin Gene-Mediated Growth Inhibition of Lung Adenocarcinoma in an Animal Model of Pleural Malignancy

  1998cited by this paper
• In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancer

  1998cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• Cis-acting region associated with lung cell-specific expression of the secretory leukoprotease inhibitor gene.

  1997cited by this paper
• Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.

  1996cited by this paper
• Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements.

  1996cited by this paper
• A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.

  1996cited by this paper
• Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.

  1996cited by this paper
• Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma.

  1996cited by this paper
• Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

  1996cited by this paper
• Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells.

  1996cited by this paper
• Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas.

  1995cited by this paper
• Multiple Bcl-2 family members demonstrate selective dimerizations with Bax.

  1995cited by this paper
• Induction of apoptosis by the Bcl-2 homologue Bak

  1995cited by this paper
• High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.

  1994cited by this paper
• Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma.

  1994cited by this paper
• Functional analysis of the 5'-flanking region of the human gastrin-releasing peptide gene in small cell lung carcinoma cell lines.

  1994cited by this paper
• Strategy for achieving selective killing of carcinomas.

  1994cited by this paper
• Specific association of human telomerase activity with immortal cells and cancer.

  1994cited by this paper
• Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene.

  1994cited by this paper
• Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

  1994cited by this paper
• Surfactant Protein A-Directed Toxin Gene Kills Lung Cancer Cells In Vitro

  1994cited by this paper
• Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model.

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

  1992cited by this paper
• Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers

  1992cited by this paper
• CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas.

  1992cited by this paper
• The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern.

  1991cited by this paper
• Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

  1991cited by this paper
• Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.

  1989cited by this paper
• Active production and membrane anchoring of carcinoembryonic antigen observed in normal colon mucosa.

  1988cited by this paper
• Ontogeny of neuroendocrine cells in human fetal lung. II. An immunohistochemical study.

  1985cited by this paper
• Neoplasms of the lung.

  1978cited by this paper

• The (re)emergence of aerosol delivery: Treatment of pulmonary diseases and its clinical challenges.

  2025cites this paper
• Dual peptides-modified cationic liposomes for enhanced Lung cancer gene therapy by a gap junction regulating strategy

  2023cites this paper
• Enhancement of Tumor Cell Death by Combining gef Gene Mediated Therapy and New 1,4-Benzoxazepin-2,6-Dichloropurine Derivatives in Breast Cancer Cells

  2018cites this paper
• Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.

  2017cites this paper
• Study of the combined treatment of lung cancer using gene-loaded immunomagnetic albumin nanospheres in vitro and in vivo

  2016cites this paper
• Selective and augmented β-glucuronidase expression combined with DOX-GA3 application elicits the potent suppression of prostate cancer.

  2016cites this paper
• Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro.

  2013cites this paper
• Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo

  2013cites this paper
• Caveolin-1 knockdown is associated with the metastasis and proliferation of human lung cancer cell line NCI-H460.

  2012cites this paper
• Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells.

  2012cites this paper
• Single agent‐ and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells

  2012cites this paper
• DNase1: a new personalized therapy for cancer?

  2011cites this paper
• 肺癌基因治疗现状与展望

  2011cites this paper
• Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells

  2010cites this paper
• Pro-neural transcription factors as cancer markers

  2008cites this paper
• A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells

  2008cites this paper
• Cellular and molecular biology of lung cancer as the basis for targeted therapy

  2007cites this paper
• Effective ablation of pancreatic cancer cells in SCID mice using systemic adenoviral RIP-TK/GCV gene therapy.

  2007cites this paper
• Recent developments in the biology of lung cancer

  2006cites this paper
• Specific sensitivity of small cell lung cancer cell lines to the snake venom toxin taipoxin.

  2005cites this paper